Skip to main content
Springer logoLink to Springer
. 2024 May 6;241(8):1719. doi: 10.1007/s00213-024-06605-w

Correction to: Effects of CB1 receptor negative allosteric modulator Org27569 on oxycodone withdrawal symptoms in mice

Rhianne L Scicluna 1,2, Nicholas A Everett 1,2, Connie J Badolato 1,2, Bianca B Wilson 1,2, Michael T Bowen 1,2,✉
PMCID: PMC11269419  PMID: 38709276

Correction to: Psychopharmacology

10.1007/s00213-024-06591-z

Diarrhea Vehicle treated male, but not female, mice undergoing PW had higher incidence of diarrhea than vehicle treated control mice [Males; p < .05, Females; p > .05]. Org27569 had no effect on precipitated withdrawal induced diarrhea in either sex [all p < .05]. The lowest dose of Org27569 increased the incidence of diarrhea in male control mice [p > .05], whereas all other doses had no effect [all p > .05].

The “<” and “>” symbols in the text should be “>” and “<” respectively.

It should read:

Diarrhea Vehicle treated male, but not female, mice undergoing PW had higher incidence of diarrhea than vehicle treated control mice [Males; p < .05, Females; p > .05]. Org27569 had no effect on precipitated withdrawal induced diarrhea in either sex [all p > .05]. The lowest dose of Org27569 increased the incidence of diarrhea in male control mice [p < .05], whereas all other doses had no effect [all p > .05].

The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1007/s00213-024-06591-z.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Psychopharmacology are provided here courtesy of Springer

RESOURCES